A survey of opioid treatment programs finds that the proportion offering on-site testing for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) declined substantially between 2000 and 2011, despite guidelines recommending routine opt-out HIV testing in all health care settings, according to a study appearing in JAMA."Opioid dependence is a risk factor for HIV, STIs, and hepatitis C virus (HCV) infection.

More...